This page is part of the 臺灣核心實作指引(TW Core IG) (v0.1.0: Releases) based on FHIR R4. This is the current published version in its permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions

• Narrative Content
• XML
• JSON
• TTL

: 臺灣藥品藥理治療分類ATC碼 - XML Representation

Active as of 2014-09-19

Raw xml | Download

<CodeSystem xmlns="http://hl7.org/fhir">
  <id value="medcation-atc-tw"/>
  <text>
    <status value="generated"/>
    <div xmlns="http://www.w3.org/1999/xhtml"><p>This code system <code>https://twcore.mohw.gov.tw/ig/twcore/CodeSystem/medcation-atc-tw</code> defines the following codes:</p><table class="codes"><tr><td style="white-space:nowrap"><b>Code</b></td><td><b>Display</b></td></tr><tr><td style="white-space:nowrap">A10BD27<a name="medcation-atc-tw-A10BD27"> </a></td><td>metformin, linagliptin and empagliflozin</td></tr><tr><td style="white-space:nowrap">A16AB22<a name="medcation-atc-tw-A16AB22"> </a></td><td>avalglucosidase alfa</td></tr><tr><td style="white-space:nowrap">C03DA05<a name="medcation-atc-tw-C03DA05"> </a></td><td>finerenone</td></tr><tr><td style="white-space:nowrap">D11AH08<a name="medcation-atc-tw-D11AH08"> </a></td><td>abrocitinib</td></tr><tr><td style="white-space:nowrap">G04BD14<a name="medcation-atc-tw-G04BD14"> </a></td><td>imidafenacin</td></tr><tr><td style="white-space:nowrap">H01BA06<a name="medcation-atc-tw-H01BA06"> </a></td><td>argipressin</td></tr><tr><td style="white-space:nowrap">J05AB04<a name="medcation-atc-tw-J05AB04"> </a></td><td>ribavirin</td></tr><tr><td style="white-space:nowrap">J05AX11<a name="medcation-atc-tw-J05AX11"> </a></td><td>elvitegravir</td></tr><tr><td style="white-space:nowrap">J05AX12<a name="medcation-atc-tw-J05AX12"> </a></td><td>dolutegravir</td></tr><tr><td style="white-space:nowrap">J05AX67<a name="medcation-atc-tw-J05AX67"> </a></td><td>ombitasvir, paritaprevir and ritonavir</td></tr><tr><td style="white-space:nowrap">J05AX68<a name="medcation-atc-tw-J05AX68"> </a></td><td>elbasvir and grazoprevir</td></tr><tr><td style="white-space:nowrap">L01FX18<a name="medcation-atc-tw-L01FX18"> </a></td><td>amivantamab</td></tr><tr><td style="white-space:nowrap">L01XE01<a name="medcation-atc-tw-L01XE01"> </a></td><td>imatinib</td></tr><tr><td style="white-space:nowrap">L01XE03<a name="medcation-atc-tw-L01XE03"> </a></td><td>erlotinib</td></tr><tr><td style="white-space:nowrap">L01XE06<a name="medcation-atc-tw-L01XE06"> </a></td><td>dasatinib</td></tr><tr><td style="white-space:nowrap">L01XE10<a name="medcation-atc-tw-L01XE10"> </a></td><td>everolimus</td></tr><tr><td style="white-space:nowrap">L01XE11<a name="medcation-atc-tw-L01XE11"> </a></td><td>pazopanib</td></tr><tr><td style="white-space:nowrap">L01XE31<a name="medcation-atc-tw-L01XE31"> </a></td><td>nintedanib</td></tr><tr><td style="white-space:nowrap">L01XX14<a name="medcation-atc-tw-L01XX14"> </a></td><td>tretinoin</td></tr><tr><td style="white-space:nowrap">L01XX17<a name="medcation-atc-tw-L01XX17"> </a></td><td>topotecan</td></tr><tr><td style="white-space:nowrap">L01XX19<a name="medcation-atc-tw-L01XX19"> </a></td><td>irinotecan</td></tr><tr><td style="white-space:nowrap">L01XX32<a name="medcation-atc-tw-L01XX32"> </a></td><td>bortezomib</td></tr><tr><td style="white-space:nowrap">L01XX73<a name="medcation-atc-tw-L01XX73"> </a></td><td>sotorasib</td></tr><tr><td style="white-space:nowrap">L04AA52<a name="medcation-atc-tw-L04AA52"> </a></td><td>ofatumumab</td></tr><tr><td style="white-space:nowrap">N05CM21<a name="medcation-atc-tw-N05CM21"> </a></td><td>lemborexant</td></tr><tr><td style="white-space:nowrap">H01AC08<a name="medcation-atc-tw-H01AC08"> </a></td><td>somatrogon</td></tr><tr><td style="white-space:nowrap">L01EX22<a name="medcation-atc-tw-L01EX22"> </a></td><td>selpercatinib</td></tr></table></div>
  </text>
  <url
       value="https://twcore.mohw.gov.tw/ig/twcore/CodeSystem/medcation-atc-tw"/>
  <version value="2022-10-24"/>
  <name value="TWMedcationATC"/>
  <title value="臺灣藥品藥理治療分類ATC碼"/>
  <status value="active"/>
  <experimental value="false"/>
  <date value="2014-09-19"/>
  <contact>
    <name value="衛生福利部"/>
    <telecom>
      <system value="url"/>
      <value value="https://www.mohw.gov.tw/"/>
    </telecom>
    <telecom>
      <system value="email"/>
      <value value="CCYU@mohw.gov.tw"/>
    </telecom>
  </contact>
  <description
               value="臺灣藥品藥理治療分類ATC碼，參照至[https://data.gov.tw/dataset/9119](https://data.gov.tw/dataset/9119)，資料提供單位：衛生福利部食品藥物管理署。  
此代碼為WHO ATC(http://www.whocc.no/atc)中未涵蓋之代碼，為符合國內代碼使用，故將未被定義之代碼另外呈現。  

*因原始資料無代碼版本資訊，故使用其「更新日期」作為版本資訊。*"/>
  <copyright value="衛生福利部食品藥物管理署"/>
  <caseSensitive value="true"/>
  <content value="complete"/>
  <count value="27"/>
  <concept>
    <code value="A10BD27"/>
    <display value="metformin, linagliptin and empagliflozin"/>
  </concept>
  <concept>
    <code value="A16AB22"/>
    <display value="avalglucosidase alfa"/>
  </concept>
  <concept>
    <code value="C03DA05"/>
    <display value="finerenone"/>
  </concept>
  <concept>
    <code value="D11AH08"/>
    <display value="abrocitinib"/>
  </concept>
  <concept>
    <code value="G04BD14"/>
    <display value="imidafenacin"/>
  </concept>
  <concept>
    <code value="H01BA06"/>
    <display value="argipressin"/>
  </concept>
  <concept>
    <code value="J05AB04"/>
    <display value="ribavirin"/>
  </concept>
  <concept>
    <code value="J05AX11"/>
    <display value="elvitegravir"/>
  </concept>
  <concept>
    <code value="J05AX12"/>
    <display value="dolutegravir"/>
  </concept>
  <concept>
    <code value="J05AX67"/>
    <display value="ombitasvir, paritaprevir and ritonavir"/>
  </concept>
  <concept>
    <code value="J05AX68"/>
    <display value="elbasvir and grazoprevir"/>
  </concept>
  <concept>
    <code value="L01FX18"/>
    <display value="amivantamab"/>
  </concept>
  <concept>
    <code value="L01XE01"/>
    <display value="imatinib"/>
  </concept>
  <concept>
    <code value="L01XE03"/>
    <display value="erlotinib"/>
  </concept>
  <concept>
    <code value="L01XE06"/>
    <display value="dasatinib"/>
  </concept>
  <concept>
    <code value="L01XE10"/>
    <display value="everolimus"/>
  </concept>
  <concept>
    <code value="L01XE11"/>
    <display value="pazopanib"/>
  </concept>
  <concept>
    <code value="L01XE31"/>
    <display value="nintedanib"/>
  </concept>
  <concept>
    <code value="L01XX14"/>
    <display value="tretinoin"/>
  </concept>
  <concept>
    <code value="L01XX17"/>
    <display value="topotecan"/>
  </concept>
  <concept>
    <code value="L01XX19"/>
    <display value="irinotecan"/>
  </concept>
  <concept>
    <code value="L01XX32"/>
    <display value="bortezomib"/>
  </concept>
  <concept>
    <code value="L01XX73"/>
    <display value="sotorasib"/>
  </concept>
  <concept>
    <code value="L04AA52"/>
    <display value="ofatumumab"/>
  </concept>
  <concept>
    <code value="N05CM21"/>
    <display value="lemborexant"/>
  </concept>
  <concept>
    <code value="H01AC08"/>
    <display value="somatrogon"/>
  </concept>
  <concept>
    <code value="L01EX22"/>
    <display value="selpercatinib"/>
  </concept>
</CodeSystem>